INS and Hyperinsulinemia: JLD can greatly reduce the level of HbA1c especially in those with HbA1c > 8.5%, significantly alleviate insulin resistance in patients with hyperinsulinemia (insulin levels > 20 mU/L) and improve β-cell function with hypoinsulinemia (insulin levels ≤ 20 mUI/L)10.